Group One Trading
SRPT icon

Group One Trading’s Sarepta Therapeutics SRPT Stock Holding History

Group One Trading’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.17M Sell
99,915
-40,859
-29% -$791K ﹤0.01% 1996
2025
Q4 		$3.03M Buy
140,774
+18,433
+15% +$388K 0.01% 1907
2025
Q3 		$2.36M Sell
122,341
-19,993
-14% -$356K ﹤0.01% 2150
2025
Q2 		$2.43M Buy
142,334
+89,779
+171% +$3.83M 0.01% 1942
2025
Q1 		$3.35M Sell
52,555
-1,573
-3% -$166K 0.01% 1381
2024
Q4 		$6.58M Buy
54,128
+17,083
+46% +$2.09M 0.02% 964
2024
Q3 		$4.63M Buy
+37,045
New +$5.12M 0.01% 1064
2024
Q2 		– Sell
-22,262
Closed -$2.86M – 7442
2024
Q1 		$2.88M Sell
22,262
-112,967
-84% -$13.8M 0.01% 1220
2023
Q4 		$13M Sell
135,229
-27,583
-17% -$2.65M 0.03% 536
2023
Q3 		$19.7M Sell
162,812
-5,036
-3% -$569K 0.07% 237
2023
Q2 		$19.2M Sell
167,848
-34,072
-17% -$4.39M 0.06% 250
2023
Q1 		$27.8M Buy
201,920
+181,444
+886% +$23.5M 0.1% 144
2022
Q4 		$2.65M Buy
20,476
+4,292
+27% +$497K 0.01% 1599
2022
Q3 		$1.79M Sell
16,184
-58,731
-78% -$5.92M ﹤0.01% 2013
2022
Q2 		$5.62M Buy
+74,915
New +$5.51M 0.01% 1213
2022
Q1 		– Sell
-115,055
Closed -$8.81M – 8664
2021
Q4 		$10.4M Buy
115,055
+4,403
+4% +$376K 0.01% 1082
2021
Q3 		$10.2M Buy
110,652
+37,993
+52% +$2.93M 0.01% 1049
2021
Q2 		$5.65M Sell
72,659
-79,879
-52% -$6.06M 0.01% 1576
2021
Q1 		$11.4M Buy
152,538
+84,166
+123% +$7.77M 0.02% 846
2020
Q4 		$11.7M Buy
68,372
+40,819
+148% +$6.05M 0.02% 716
2020
Q3 		$3.87M Buy
+27,553
New +$4.19M 0.01% 1088
2020
Q2 		– Sell
-36,542
Closed -$4.97M – 6154
2020
Q1 		$3.58M Buy
36,542
+35,052
+2,352% +$4.01M 0.03% 706
2019
Q4 		$192K Buy
1,490
+69
+5% +$6.96K ﹤0.01% 3205
2019
Q3 		$107K Buy
+1,421
New +$168K ﹤0.01% 3513
2018
Q1 		– Sell
-55,446
Closed -$3.7M – 5280
2017
Q4 		$3.08M Sell
55,446
-138,909
-71% -$7.36M 0.02% 915
2017
Q3 		$8.82M Buy
194,355
+151,573
+354% +$6.06M 0.08% 298
2017
Q2 		$1.44M Sell
42,782
-79,877
-65% -$2.6M 0.02% 1185
2017
Q1 		$3.63M Buy
+122,659
New +$3.8M 0.04% 546
2016
Q3 		– Sell
-571,145
Closed -$17.3M – 4885
2016
Q2 		$10.9M Buy
571,145
+508,268
+808% +$9.41M 0.13% 152
2016
Q1 		$1.23M Sell
62,877
-235,234
-79% -$4.11M 0.02% 1041
2015
Q4 		$11.5M Sell
298,111
-6,503
-2% -$211K 0.14% 137
2015
Q3 		$9.78M Buy
304,614
+73,618
+32% +$2.5M 0.14% 156
2015
Q2 		$7.03M Buy
230,996
+96,347
+72% +$1.97M 0.1% 221
2015
Q1 		$1.79M Sell
134,649
-9,456
-7% -$126K 0.03% 705
2014
Q4 		$2.08M Buy
144,105
+63,156
+78% +$1.07M 0.03% 620
2014
Q3 		$1.71M Buy
80,949
+32,642
+68% +$737K 0.03% 778
2014
Q2 		$1.44M Sell
48,307
-44,796
-48% -$1.42M 0.02% 903
2014
Q1 		$2.24M Sell
93,103
-100,575
-52% -$2.56M 0.04% 572
2013
Q4 		$3.94M Buy
193,678
+184,451
+1,999% +$5.48M 0.06% 334
2013
Q3 		$436K Sell
9,227
-51,626
-85% -$1.99M 0.01% 1733
2013
Q2 		$2.31M Buy
+60,853
New +$2.18M 0.06% 349

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's SRPT Position: Q1 2026 in Review

Group One Trading reduced its Sarepta Therapeutics (SRPT) stake by 29% in Q1 2026, selling an estimated $791K and leaving 99,915 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1996.

Group One Trading first reported a position in SRPT in Q2 2013 and has held it in 41 quarters since. The position peaked at $27.8M in Q1 2023. 339 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Group One Trading held 99,915 shares of Sarepta Therapeutics worth $2.17M as of Q1 2026.
  • Group One Trading sold 40,859 Sarepta Therapeutics shares in Q1 2026, an estimated $791K.
  • Sarepta Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #1996 holding.
  • Group One Trading first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 41 quarters since.
  • Group One Trading's Sarepta Therapeutics position peaked at $27.8M in Q1 2023.
  • 339 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.